2006•Xinxueguan kangfu yixue zazhiRequires access

Captoplil treatment for patient with acute myocardial infarction complicated atrial fibrillation

Zhao Xu

Open publisher page 0 citations

Abstract

Objective:To study the significance of captoplil treatment on patient with acute myocardial infarction(AMI) complicated atrial fibrillation.Methods:A total of 63 AMI patients complicated atrial fibrillation were randomly divided into captoplil treatment group (32 cases) and control group(without captoplil treatment,31 cases).Results:Recurrence rate of paroxysmal atrial fibrillation (12.5%),incidence rate transformed persistence atrial fibrillation (6.2%),and incidence rate of event correlated ischemia (25%) in captoplil treatment group were significantly less than those of control group (P0.05).Conclusion:Captoplil can decrease recurrence rate of paroxysmal atrial fibrillation and incidence rate of event correlated ischemia in AMI patient complicated atrial fibrillation.

About this research paper

What this paper is about

Objective:To study the significance of captoplil treatment on patient with acute myocardial infarction(AMI) complicated atrial fibrillation.Methods:A total of 63 AMI patients complicated atrial fibrillation were randomly divided into captoplil treatment group (32 cases) and control group(without captoplil treatment,31 cases).Results:Recurrence rate of paroxysmal atrial fibrillation (12.5%),incidence rate transformed persistence atrial fibrillation (6.2%),and incidence rate of event correlated ischemia (25%) in captoplil treatment group were significantly less than those of control group (P0.05).Conclusion:Captoplil can decrease recurrence rate of paroxysmal atrial fibrillation and incidence rate of event correlated ischemia in AMI patient complicated atrial fibrillation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the significance of captoplil treatment on patient with acute myocardial infarction(AMI) complicated atrial fibrillation.Methods:A total of 63 AMI patients complicated atrial fibrillation were randomly divided into captoplil treatment group (32 cases) and control group(without captoplil treatment,31 cases).Results:Recurrence rate of paroxysmal atrial fibrillation (12.5%),incidence rate transformed persistence atrial fibrillation (6.2%),and incidence rate of event correlated ischemia (25%) in captoplil treatment group were significantly less than those of control group (P0.05).Conclusion:Captoplil can decrease recurrence rate of paroxysmal atrial fibrillation and incidence rate of event correlated ischemia in AMI patient complicated atrial fibrillation.

Key concepts: Medicine, Atrial fibrillation, Cardiology, Internal medicine, Incidence (geometry), Myocardial infarction, Fibrillation, Optics

Related papers

Back to paper searchBrowse research topicsOriginal source
Captoplil treatment for patient with acute myocardial infarction complicated atrial fibrillation — Research Paper | ScholarLens